We are live on
!
Find out more
RG
Renaissance Group Portfolio holdings
AUM
$2.39B
1-Year Est. Return
27.81%
This Fund
S&P 500
This Quarter
Est. Return
+11.27%
1 Year Est. Return
+27.81%
3 Year Est. Return
+92.11%
5 Year Est. Return
+135.4%
10 Year Est. Return
+451.85%
AUM
$2.33B
AUM Growth
+$164M
(+7.6%)
Cap. Flow
-$97.3M
Cap. Flow
% of AUM
-4.18%
Top 10 Holdings %
Top 10 Hldgs %
15.49%
Holding
295
New
60
Increased
61
Reduced
154
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Revvity
RVTY
|
+$26.1M |
| 2 |
Ericsson
ERIC
|
+$9.67M |
| 3 |
ICICI Bank
IBN
|
+$9.39M |
| 4 |
STMP
Stamps.com, Inc.
STMP
|
+$1.12M |
| 5 |
AGNT
AGNT Inc
AGNT
|
+$1.09M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Express
AXP
|
+$24.4M |
| 2 |
Manulife Financial
MFC
|
+$8.31M |
| 3 |
Apple
AAPL
|
+$5.45M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$4.88M |
| 5 |
TSMC
TSM
|
+$4.08M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.71% |
| 2 | Healthcare | 15.01% |
| 3 | Industrials | 10.97% |
| 4 | Communication Services | 8.1% |
| 5 | Financials | 7.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
CenterPoint Energy
CNP
$26.8B
| $225K | 0.01% |
+10,419
| New | +$231K |
|
227
General Dynamics
GD
$106B
| $223K | 0.01% |
+1,501
| New | +$219K |
|
228
Masco
MAS
$15.3B
| $223K | 0.01% |
+4,056
| New | +$223K |
|
229
IBM
IBM
$224B
| $221K | 0.01% |
+1,840
| New | +$213K |
|
230
Valero Energy
VLO
$85.9B
| $212K | 0.01% |
+3,746
| New | +$184K |
|
231
Ingredion
INGR
$6.58B
| $201K | 0.01% |
+2,561
| New | +$197K |
|
|
AXON
232
Axon Enterprise
AXON
$46.4B
| – | – |
-10,720
| Closed | -$972K |
|
|
233
American Express
AXP
$230B
| – | – |
-242,929
| Closed | -$24.4M |
|
234
Biogen
BIIB
$30.7B
| – | – |
-2,208
| Closed | -$626K |
|
235
Colliers International
CIGI
$5.19B
| – | – |
-7,090
| Closed | -$473K |
|
236
e.l.f. Beauty
ELF
$5.8B
| – | – |
-44,602
| Closed | -$819K |
|
237
Gilead Sciences
GILD
$165B
| – | – |
-11,080
| Closed | -$700K |
|
238
John B. Sanfilippo & Son
JBSS
$972M
| – | – |
-8,883
| Closed | -$670K |
|
239
Lattice Semiconductor
LSCC
$18.5B
| – | – |
-38,586
| Closed | -$1.12M |
|
|
240
Manulife Financial
MFC
$73.5B
| – | – |
-597,258
| Closed | -$8.31M |
|
|
JBTM
241
JBT Marel
JBTM
$6.39B
| – | – |
-6,694
| Closed | -$615K |
|
|
IPHI
242
DELISTED
INPHI CORPORATION
IPHI
| – | – |
-7,360
| Closed | -$826K |
|
|
BEAT
243
DELISTED
BioTelemetry, Inc.
BEAT
| – | – |
-16,009
| Closed | -$730K |
|
|
QIWI
244
DELISTED
QIWI PLC
QIWI
| – | – |
-25,686
| Closed | -$446K |
|
Similar funds
DSCM
PA
VF
SCA
PUI
EC
HFM
CC
Renaissance Group's Q4 2020 Portfolio in Review
As of Q4 2020, Renaissance Group held 295 positions worth $2.33B, up 7.6% from $2.16B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Renaissance Group withdrew a net $97.3M in Q4 2020, closing 16 positions and reducing 154 holdings. Its most notable exit was American Express, an estimated $24.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Renaissance Group opened a new position in Revvity worth $28.1M.
- Renaissance Group's largest Q4 2020 buy was Revvity: 196,077 shares worth $28.1M.
- Renaissance Group added most to Vertex Pharmaceuticals in Q4 2020, an estimated $952K increase.
- Renaissance Group's biggest Q4 2020 reduction was Apple, cutting an estimated $5.45M.
- Renaissance Group fully exited American Express in Q4 2020, selling an estimated $24.4M.
- Renaissance Group's ten largest holdings make up 15% of its $2.33B portfolio in Q4 2020.
- Renaissance Group opened 60 new positions and closed 16 in Q4 2020.
- Renaissance Group's portfolio value rose 7.6% quarter-over-quarter to $2.33B.
Based on Renaissance Group's 13F filing for Q4 2020, filed 12 Feb 2021.